Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

362

datasets available to search

ShareScore release 0.7.1

Reset

Dataset results

362 results for “risk analysis”

Learn how ShareScore rates datasets ↗
zenodo32/100

Risk Assessment and Radiomics Analysis in Magnetic Resonance Imaging of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN)

<p>I uploaded the original images of the manuscript "Risk Assessment and Radiomics Analysis in Magnetic Resonance Imaging of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN)" accepted for pubblication on Cancer Control.</p>

opencc-by-4.0Jun 2024View details →
zenodo32/100

Risk Level Analysis of Land Contaminated with B3 Waste from Traditional Oil Mining Activities in Wonocolo Village, Kedewan District, Bojonegoro Regency, East Java Province

<p>This material has presented on 2nd International Conference on Advanced Research in Engineering and Technology in October 25, 2023.</p>

opencc-by-4.0Jun 2024View details →
zenodo32/100

Correlation analysis for paper "Energy Storage Profit Risk under Stochastic Fuel Prices"

<p>This is a supplementary data for reproducibility.</p>

opencc-by-4.0Apr 2018View details →
zenodo32/100

Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort

<p>Background: While numerous epidemiologic studies have found an association between higher serum 25-hydroxyvitamin D [25(OH)D] concentrations and lower breast cancer risk, few have assessed this association for concentrations &gt;40 ng/ml.</p> <p>&nbsp;</p> <p>Objective: To investigate the relationship between 25(OH)D concentration and breast cancer risk across a broad range of 25(OH)D concentrations among women aged 55 years and older.</p> <p>&nbsp;</p> <p>Methods: Analyses used pooled data from two randomized clinical trials (N=1129, N=2196) and a prospective cohort (N=1713) to examine a broad range of 25(OH)D concentrations. The outcome was diagnosis of breast cancer during the observation periods (median: 4.0 years). Three analyses were conducted: 1) Incidence rates were compared according to 25(OH)D concentration from &lt;20 to &ge;60 ng/ml (&lt;50 to &ge;150 nmol/L), 2) Kaplan-Meier plots were developed and 3) multivariate Cox regression was used to examine the association between 25(OH)D and breast cancer risk using multiple 25(OH)D measurements.</p> <p>&nbsp;</p> <p>Results: Within the pooled cohort (N=5038), 77 women were diagnosed with breast cancer (age-adjusted incidence: 512 cases per 100,000 person-years). Results were similar for the three analyses. First, comparing incidence rates, there was an 82% lower incidence rate of breast cancer for women with 25(OH)D concentrations &ge;60 vs &lt;20 ng/ml (Rate Ratio=0.18, <em>P</em>=0.006). Second, Kaplan-Meier curves for concentrations of &lt;20, 20-39, 40-59 and &ge;60 ng/ml were significantly different (<em>P</em>=0.02), with the highest proportion breast cancer-free in the &ge;60 ng/ml group (99.3%) and the lowest proportion breast cancer-free in the &lt;20 ng/ml group (96.8%). The proportion with breast cancer was 78% lower for &ge;60 vs &lt;20 ng/ml (<em>P</em>=0.02). Third, multivariate Cox regression revealed that women with 25(OH)D concentrations &ge;60 ng/ml had an 80% lower risk of breast cancer than women with concentrations &lt;20 ng/ml (HR=0.20, <em>P</em>=0.03), adjusting for age, BMI, smoking status, calcium supplement intake, and study of origin.</p> <p>&nbsp;</p> <p>Conclusions: Higher 25(OH)D concentrations were associated with a dose-response decrease in breast cancer risk with concentrations &ge;60 ng/ml being most protective.</p>

opencc-by-4.0Apr 2018View details →
zenodo32/100

Supplementary material 1 from: Clarke S, Stenekes N, Kancans R, Woodland C, Robinson A (2018) Undelivered risk: A counter-factual analysis of the biosecurity risk avoided by inspecting international mail articles. NeoBiota 40: 73-86. https://doi.org/10.3897/neobiota.40.28840

Variogram of the residuals of the random forest model : Explanation note: A variogram designed to visually assess whether there is spatial correlation present in the residuals of the random forest model. This does not indicate any spatial correlation.

opencc-zeroDec 2018View details →
dryad32/100

Reconstructing the historical fauna of a large continental island: a multispecies reintroduction risk analysis

<p>1. Reintroduction projects, which are an important tool in threatened species conservation, are becoming more complex, often involving the translocation of multiple species. Ecological theory predicts that the sequence and timing of reintroductions will play an important role in their success or failure. Following the removal of sheep, goats and feral cats, the Western Australian government is sequentially reintroducing 13 native fauna species to restore the globally important natural and cultural values of Dirk Hartog Island.</p> <p>2. We use ensembles of ecosystem models to compare 23 alternative reintroduction strategies on Dirk Hartog Island, in Western Australia. The reintroduction strategies differ in the order, timing, and location of releases on the island. Expert elicitation informed the model structure, allowing for use of different presumed species interaction networks which explicitly incorporated uncertainty in ecosystem dynamics.</p> <p>3. Our model ensembles predict that almost all of the species (~12.5 out of 13, on average) will successfully establish in the ecosystem studied, regardless of which reintroduction strategy is undertaken. The project can therefore proceed with greater confidence and flexibility regarding the reintroduction strategy. However, the identity of the at-risk species varies between strategies, and depends on the structure of the species interaction network, which is quite uncertain. The model ensembles also offer insights into why some species fail to establish on Dirk Hartog Island, predicting that most unsuccessful reintroductions will be the result of competitive interactions with extant species.</p> <p>4. <i>Synthesis and applications:</i> Our model ensembles allow for the comparison of outcomes between reintroduction strategies and between different species interaction networks. This framework allows for inclusion of high uncertainty in dynamics. Finally, an ensemble modelling approach also creates a foundation for formal adaptive management as reintroduction projects proceed.</p>

opencc-zeroJun 2021View details →
zenodo32/100

SESMG Model Definitions: "Potential-Risk and No-Regret Options for Urban Energy System Design - A Sensitivity Analysis"

<p>Each of the files is one SESMG model definition used for the study&nbsp;&quot;Potential-Risk and No-Regret Options for Urban Energy System Design - A Sensitivity Analysis&quot;. Further information can be found in this publication. The file names indicate to which sensitivity analysis of the study the individual model definition belongs to. Used acronyms: &quot;ng&quot; = natural gas.</p>

opencc-by-4.0Jun 2023View details →
zenodo32/100

SESMG Model Results: "Potential-Risk and No-Regret Options for Urban Energy System Design - A Sensitivity Analysis"

<p>Each of the folders contains SESMG results for a sensitivity analysis of the study &quot;Potential-Risk and No-Regret Options for Urban Energy System Design - A Sensitivity Analysis&quot;. More information can be found in this publication. Each folder contains two subfolders. The &quot;cost-minimum&quot; subfolder contains the results for financially optimized systems, and the &quot;emission-minimum&quot; subfolder contains the results for GHG emission-optimized systems. Within these subfolders, the results for different gradations of the respective sensitivity parameters are stored in separate sub-subfolders. The 01_reference_total_ghg_emissions folder has a slightly different structure. Since the results are not separated into financially and emissions-optimized scenarios, the results of different gradations are stored directly in the main folder of this sensitivity analysis.</p>

opencc-by-4.0Jun 2023View details →
ClinicalTrials.gov32/100

Familial Analysis of Keratoconus Risk

ClinicalTrials.gov study NCT02812563. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Analysis of Risk Factors of Neurodevelopmental Disorder in Deaf Infants Under Ten Months of Age.

ClinicalTrials.gov study NCT05423548. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Risk Factors for Pediatric Emergence Agitation and Analysis of Serum or Urine Metabonomics in Children With Agitation

ClinicalTrials.gov study NCT04807998. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Risk Factors Analysis for Clinical Important Postoperative Nausea and Vomiting

ClinicalTrials.gov study NCT06445920. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Investigation on the Current Situation and Risk Factors Analysis of Exocrine Insufficiency in Chronic Pancreatitis

ClinicalTrials.gov study NCT06946108. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase

ClinicalTrials.gov study NCT03980639. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Individual Patient Data Meta-analysis on Prehospital Risk Assessment in Patients Suspected of Non-ST-segment Elevation Acute Coronary Syndrome

ClinicalTrials.gov study NCT06051110. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients

ClinicalTrials.gov study NCT01446510. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Risk Analysis for Diabetic Cardiovascular Autonomic Neuropathy

ClinicalTrials.gov study NCT02461472. IPD Sharing: Not stated. Countries: 1. Publications: 11.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk

ClinicalTrials.gov study NCT05309057. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

ClinicalTrials.gov study NCT02116504. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

VTE Risk Prevention System Based on Big Data Analysis and Multimodule System

ClinicalTrials.gov study NCT05969951. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record